Coherus Oncology Competitors and Similar CompaniesClear all
Genentech's competitors and similar companies include AstraZeneca and Pfizer.
 Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | |
Founding Date | Founding Date 1976 | Founding Date 1999 | Founding Date 1849 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 18,077 | Employees 94,300 | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) 163.9 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $4.9b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $54.2b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income N/A | Net income $10.2b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 130 (FY, 2021) | Countries 200 (FY, 2024) |
Phase I Trials Products | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products N/A | Phase I Trials Products 51 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company